Moreover, an additional somatic mutation was also detected in neuroendocrine components of both primary and metastatic sites, while a missense mutation in SMARCA4 gene (p.Pro171Leu) was identified only in the adenocarcinoma component of primary site (Table 1) (La Rosa et al., 2018). Here, SMARCA4 is linked to adenocarcinoma.